Sort
82,697 grants matching “vaccine development”
Chemoprophylaxis and HIV Host Interactions
$802,225J. David Gladstone Institutes · R01 · FY2005 · AI
Immunotherapy to prevent drug-resistant tuberculosis
$802,216Rhea N Coler · Access To Advanced Health Institute · R01 · FY2019 · AI
Structural mechanisms of bacteriophage infection and assembly
$802,161Brian Kelch · University Of Massachusetts Medical School · · FY2024 · BIO
The Role of Lipid-specific T cells in Mediating Protection Against M. tuberculosis
$802,099Chetan Seshadri · University Of Washington · R01 · FY2024 · AI
Reactions And Immunochemistry Of Carbohydrates
$802,050Pavol Kovac · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2013 · DK
Chemoattractant-based immunotherapeutics to modulate immune and cancer cells
$802,045Arya Arya · Aging · Z01 · FY2007 · AG
Enhancing Discovery of HIV Host Genetics using Drug Abuse and other Interactions
$801,992Eric O Johnson · Research Triangle Institute · R01 · FY2015 · DA
Development of an oral liver-targeted prime-and-trap malaria vaccine
$801,878Sean C Murphy · University Of Washington · U01 · FY2021 · AI
Mechanisms of Enhanced Neutralizing Antibody Responses to Rhinovirus C
$801,850Yury A Bochkov · University Of Wisconsin-Madison · R01 · FY2022 · AI
North-Central California-Center For AIDS Research
$801,832University Of California Davis · P30 · FY2002 · AI
DEVELOPMENT OF VACCINES FOR ORAL CARCINOMA
$801,575University Of Pittsburgh At Pittsburgh · P01 · FY2000 · DE
Understanding and optimizing antibody-based interventions against neonatal HSV infection
$801,565Margaret E Ackerman · Dartmouth College · R01 · FY2023 · AI
The Role of Lipid-specific T cells in Mediating Protection Against M. tuberculosis
$801,468Chetan Seshadri · University Of Washington · R01 · FY2021 · AI
HIV B-Cell Lineage Vaccine Design Based on Replicating SAd and Env Protein in NHP
$801,463Jeffery Alexander · Paxvax, Inc. · R44 · FY2015 · AI
Liver resident memory for malaria
$801,401Sean C Murphy · University Of Washington · R01 · FY2022 · AI
Reservoir Targeted Vaccine fo rthe Control of Lyme Borreliosis
$801,374Maria Gomes-Solecki · University Of Tennessee Health Sci Ctr · U01 · FY2008 · CK
Mechanisms of mucosal protection induced by attenuated SIV
$801,307R. Paul Johnson · Harvard Medical School · P01 · FY2011 · AI
Maturation of human humoral immunity through repeat malaria challenges
$801,244Kim C Williamson · Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2023 · AI
Impact of HIV, oral microbiome and mycobiome on oral HPV persistence
$801,143Robert D. Burk · Albert Einstein College Of Medicine · R01 · FY2024 · DE
Development of highly potent human monoclonal for RSV immuno-prophylaxis
$801,020Larry Zeitlin · Mapp Biopharmaceutical, Inc. · R44 · FY2021 · AI
MICROCHIP DRUG DELIVERY SYSTEM
$801,006Massachusetts Institute Of Technology · R24 · FY2002 · AI
EFFECT OF A MULTIPEPTIDE KRAS VACCINE IN THE PREVENTION OF PANCREATIC CANCER DRIVEN BY KRAS ONCOPROTEIN HHSN2612015000371 TORFP: 2017-E02
$800,994Ming You · Medical College Of Wisconsin · N01 · FY2017 · CA
The Impacts of Adverse Provider Conditions on Provider Bias and Health Disparities
$800,983Anastasia Makhanova · University Of Arkansas At Fayetteville · R01 · FY2024 · MD
Targeting the Epigenome for Lung Cancer Therapy
$800,874David Schrump · Division Of Clinical Sciences - Nci · ZIA · FY2010 · CA
A prophylactic vaccine to prevent colonization by Pseudomonas aeruginosa
$800,748Wendy L Picking · University Of Missouri-Columbia · R01 · FY2023 · AI